RAMM Pharma (XCNQ:RAMM) Other Operating Expense: C$0.53 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is RAMM Pharma Other Operating Expense?

RAMM Pharma XCNQ:RAMM Other Operating Expense is C$0.53 Mil as of Apr. 2026. The stock has 4 warning signs investors should review.

RAMM Pharma's Other Operating Expense for the three months ended in Apr. 2026 was C$0.10 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Apr. 2026 was C$0.53 Mil.

RAMM Pharma's quarterly Other Operating Expense declined from Oct. 2025 (C$0.18 Mil) to Jan. 2026 (C$0.10 Mil) and declined from Jan. 2026 (C$0.10 Mil) to Apr. 2026 (C$0.10 Mil).

RAMM Pharma's annual Other Operating Expense declined from Oct. 2023 (C$1.40 Mil) to Oct. 2024 (C$1.21 Mil) and declined from Oct. 2024 (C$1.21 Mil) to Oct. 2025 (C$0.79 Mil).

RAMM Pharma Other Operating Expense Historical Data

* Premium members only.

The historical data trend for RAMM Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RAMM Pharma Other Operating Expense Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Other Operating Expense
Get a 7-Day Free Trial 0.94 1.23 1.40 1.21 0.79

RAMM Pharma Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.15 0.18 0.10 0.10

RAMM Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of C$0.53 Mil mean?
RAMM Pharma (XCNQ:RAMM) has a Other Operating Expense of C$0.53 Mil as of Apr. 2026. Other operating expenses that a company records on its income statement. View historical data on RAMM Pharma and its competitors.
Is RAMM Pharma's Other Operating Expense too high?
RAMM Pharma's current Other Operating Expense is C$0.53 Mil.
How does RAMM Pharma's Other Operating Expense compare to ZTS and UTHR?
RAMM Pharma's Other Operating Expense of C$0.53 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on RAMM Pharma and its competitors. RAMM Pharma's current Other Operating Expense is C$0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RAMM Pharma stock overvalued right now?
Based on GuruFocus' analysis, RAMM Pharma (XCNQ:RAMM) is currently considered Fairly Valued. The stock's GF Value™ is C$0.01, compared to a current price of C$0.01 — trading right at its estimated fair value. The current Other Operating Expense is C$0.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For RAMM Pharma (XCNQ:RAMM), the current Other Operating Expense is C$0.53 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RAMM Pharma Business Description

Address 82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.